Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QPCT | Q16769 | 17/20 | 0.40 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.38 |
| ▸ | SNCA | P37840 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25864820 | 0.84 | QPCT (0.47) | QPCTQPCTLSNCA | |
| SCHEMBL25864786 | 0.74 | SNCA (0.38) | SNCA | |
| SCHEMBL30355776 | 0.73 | ERN1 (0.40) | QPCT | |
| SCHEMBL23523807 | 0.73 | ERN1 (0.40) | QPCT | |
| SCHEMBL12619082 | 0.71 | S1PR1 (0.58) | — | |
| Hydrochloric Acid SCHEMBL1795254 | 0.71 | S1PR1 (0.57) | — | |
| SCHEMBL1706431 | 0.69 | QPCT (0.50) | QPCT | |
| SCHEMBL30355565 | 0.68 | QPCT (0.38) | QPCT | |
| SCHEMBL23523914 | 0.68 | QPCT (0.38) | QPCT | |
| SCHEMBL25863944 | 0.68 | HSD17B1 (0.35) | QPCTQPCTL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210188826-A1 | COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME | TREVENA, INC. | 2021-06-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210188826-A1 | COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME | S1PR1, S1PR2, S1PR3 | QPCT 2503/4885QPCTL 3187/4885SNCA 2550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.